Dr Lane's account of 1981 was one of his battles to secure a commitment from the government to redevelop BPL, and to fund the improvements necessary following an adverse Medicines' Inspectorate report.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Viral Inactivation
Key Person(s)
Dr Richard S Lane